139 related articles for article (PubMed ID: 37876093)
21. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
[TBL] [Abstract][Full Text] [Related]
22. Studies in haemoglobin E beta-thalassaemia.
Olivieri NF; Muraca GM; O'Donnell A; Premawardhena A; Fisher C; Weatherall DJ
Br J Haematol; 2008 May; 141(3):388-97. PubMed ID: 18410572
[TBL] [Abstract][Full Text] [Related]
23. A commentary on molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.
Setianingsih I
J Hum Genet; 2014 Apr; 59(4):173. PubMed ID: 24500683
[No Abstract] [Full Text] [Related]
24. Beta-thalassaemia: all roads lead to a cure?
The Lancet Haematology
Lancet Haematol; 2018 Oct; 5(10):e430. PubMed ID: 30290897
[No Abstract] [Full Text] [Related]
25. Thalassaemia.
Gelbart M
Nurs Times; 1998 Jun 17-23; 94(24):39. PubMed ID: 9735798
[No Abstract] [Full Text] [Related]
26. Haemoglobin E beta thalassaemia in Sri Lanka.
Premawardhena A; Fisher CA; Olivieri NF; de Silva S; Arambepola M; Perera W; O'Donnell A; Peto TE; Viprakasit V; Merson L; Muraca G; Weatherall DJ
Lancet; 2005 Oct 22-28; 366(9495):1467-70. PubMed ID: 16243092
[TBL] [Abstract][Full Text] [Related]
27. Cell erythroid maturation approach: a new paradigm in the road map towards a cure for β-thalassaemia syndromes.
Maggio A
Br J Haematol; 2022 Feb; 196(4):806-808. PubMed ID: 34825367
[No Abstract] [Full Text] [Related]
28. Economic evaluation of betibeglogene autotemcel (Beti-cel) gene addition therapy in transfusion-dependent β-thalassemia.
Kansal AR; Reifsnider OS; Brand SB; Hawkins N; Coughlan A; Li S; Cragin L; Paramore C; Dietz AC; Caro JJ
J Mark Access Health Policy; 2021 Jun; 9(1):1922028. PubMed ID: 34178295
[No Abstract] [Full Text] [Related]
29. Molecular basis of transfusion dependent beta-thalassemia major patients in Sabah.
Teh LK; George E; Lai MI; Tan JA; Wong L; Ismail P
J Hum Genet; 2014 Mar; 59(3):119-23. PubMed ID: 24369358
[TBL] [Abstract][Full Text] [Related]
30. Spectrum of beta-thalassaemia mutations in transfusion dependent thalassaemia patients: practical implications in prenatal diagnosis.
George E; George R; Ariffin WA; Mokhtar AB; Azman ZA; Sivagengei K
Med J Malaysia; 1993 Sep; 48(3):325-9. PubMed ID: 8183146
[TBL] [Abstract][Full Text] [Related]
31. Extraordinary intrathecal bone reaction in beta-thalassaemia intermedia.
Parano E; Pavone V; Di Gregorio F; Pavone P; Trifiletti RR
Lancet; 1999 Sep; 354(9182):922. PubMed ID: 10489960
[TBL] [Abstract][Full Text] [Related]
32. A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies?
Cappellini MD; Porter JB; Viprakasit V; Taher AT
Blood Rev; 2018 Jul; 32(4):300-311. PubMed ID: 29455932
[TBL] [Abstract][Full Text] [Related]
33. Health related quality of life among children with transfusion dependent β-thalassaemia major and haemoglobin E β-thalassaemia in Sri Lanka: a case control study.
Mettananda S; Pathiraja H; Peiris R; Bandara D; de Silva U; Mettananda C; Premawardhena A
Health Qual Life Outcomes; 2019 Aug; 17(1):137. PubMed ID: 31395066
[TBL] [Abstract][Full Text] [Related]
34. Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia.
Gringras P; Wonke B; Old J; Fitches A; Valler D; Kuan AM; Hoffbrand V
Arch Dis Child; 1994 Jan; 70(1):30-4. PubMed ID: 7509151
[TBL] [Abstract][Full Text] [Related]
35. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
George E; Wong HB
Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
[TBL] [Abstract][Full Text] [Related]
36. Zynteglo: Betibeglogene autotemcel - An innovative therapy for β- thalassemia patients.
Asghar AA; Khabir Y; Hashmi MR
Ann Med Surg (Lond); 2022 Oct; 82():104624. PubMed ID: 36268391
[No Abstract] [Full Text] [Related]
37. Delta-Beta Thalassaemia in a Pathan Family.
Ahmad SQ; Zafar SI; Malik HS; Ahmed S
J Coll Physicians Surg Pak; 2017 Nov; 27(11):722-724. PubMed ID: 29132487
[TBL] [Abstract][Full Text] [Related]
38. Optimal management of β thalassaemia intermedia.
Taher AT; Musallam KM; Cappellini MD; Weatherall DJ
Br J Haematol; 2011 Mar; 152(5):512-23. PubMed ID: 21250971
[TBL] [Abstract][Full Text] [Related]
39. The frequency of synovitis and calcium pyrophosphate deposition with ultrasound is increased in transfusion-dependent beta-thalassaemia patients: effect of iron accumulation?
Ermurat S; Güler Kazancı E; Ayar K; Gürsoy V
Clin Exp Rheumatol; 2023 May; 41(5):1059-1067. PubMed ID: 36062740
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetics and prenatal diagnosis of beta thalassemia to control transfusion dependent births in carrier Pakistani couples.
Kanwal S; Bukhari S; Perveen S
J Pak Med Assoc; 2017 Jul; 67(7):1030-1034. PubMed ID: 28770881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
